pre-procedural abnormal function of von willebrand factor is predictive of bleeding after surgical but not transcatheter aortic valve replacement

Both transcatheter aortic valve implantation (tavi) and surgical aortic valve replacement (savr) have been proven to effectively correct von willebrand factor (vwf) pathologies, however there is limited data simultaneously comparing outcomes of both approaches. we prospectively enrolled patients with severe aortic stenosis referred for tavi (n = 52) or savr (n = 48). in each case, vwf antigen (vwf:ag), vwf activity (vwf:ac) and activity-to-antigen (vwf:ac/ag) ratio were assessed at baseline, 24 h and 72 h after procedure. vwf abnormalities were defined as reduced vwf:ac/ag ratio (< 0.8). bleeding events in both arms were classified according to valve academic research consortium (varc-2) definitions. overall, there was no difference between patients referred for tavi and savr in vwf:ac (1.62 ± 0.52 vs 1.71 ± 0.64; p = 0.593), vwf:ag (1.99 ± 0.81 vs 2.04 ± 0.81; p = 0.942) or vwf:ac/ag ratio (0.84 ± 0.16 vs 0.85 ± 0.12; p = 0.950). pathological vwf:ac/ag ratio was found in 20 (38%) tavi and 15 (31%) savr patients (p = 0.407). normalization of vwf:ac/ag ratio at day 3 after procedure was achieved in 19 (95%) tavi and 13 (87%) savr patients (p = 0.439). similar prevalence of major or life-threatening bleedings (mltb) after tavi and savr in entire groups was observed (19% vs. 23%, p = 0.652). vwf abnormalities were associated with higher incidence of mltb in savr (53% vs 9%, p < 0.001), but not tavi (15% vs. 22%, p = 0.132). accordingly, in receiver-operating characteristic curve analysis vwf:ac/ag ratio < 0.8 showed significant sensitivity and specificity for predicting mltb in savr group (auc 0.735, 95% ci 0.538–0.931, p = 0.019). we proved that abnormal function of vwf is corrected successfully after both tavi and savr, but vwf abnormalities are predictive of mltb only in surgical patients.